Sean Gaffney - Nov 17, 2022 Form 4 Insider Report for Addus HomeCare Corp (ADUS)

Signature
/s/ Brian Poff, Attorney-In-Fact for Sean Gaffney
Stock symbol
ADUS
Transactions as of
Nov 17, 2022
Transactions value $
-$383,179
Form type
4
Date filed
11/21/2022, 04:16 PM
Previous filing
Aug 8, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADUS Common Stock Options Exercise $456K +6.63K +51.66% $68.89 19.5K Nov 17, 2022 Direct
transaction ADUS Common Stock Sale -$709K -6.63K -34.06% $107.07 12.8K Nov 17, 2022 Direct F1
transaction ADUS Common Stock Options Exercise $232K +3.37K +26.31% $68.89 16.2K Nov 18, 2022 Direct
transaction ADUS Common Stock Sale -$353K -3.28K -20.26% $107.46 12.9K Nov 18, 2022 Direct F2
transaction ADUS Common Stock Sale -$9.95K -92 -0.71% $108.15 12.8K Nov 18, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADUS Employee Stock Option (right to buy) Options Exercise $0 -6.63K -33.13% $0.00 13.4K Nov 17, 2022 Common Stock 6.63K $68.89 Direct F4
transaction ADUS Employee Stock Option (right to buy) Options Exercise $0 -3.37K -25.23% $0.00 10K Nov 18, 2022 Common Stock 3.37K $68.89 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.99, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.11 to $108.28, inclusive.
F4 The shares vest in equal installments on each of the first four anniversaries of the grant date.